| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
-0.018 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |